The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A

Hepatology

Volumn 54, Issue 5, 2011, Pages 1506-1517

  Helbig, Karla J ^a,b   Eyre, Nicholas S ^a   Yip, Evelyn ^a   Narayana, Sumudu ^a   Li, Kui ^c   Fiches, Guillaume ^a   Mccartney, Erin M ^a   Jangra, Rohit K ^d,e   Lemon, Stanley M ^d,f   Beard, Michael R ^a  

^a University of Adelaide   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; FAT DROPLET; NONSTRUCTURAL PROTEIN 5A; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN SUBTYPE A; VIPERIN; VIRUS PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG DISTRIBUTION; ENDOPLASMIC RETICULUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; MUTAGENESIS; PROTEINS; RNA, SMALL INTERFERING; VESICULAR TRANSPORT PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 80055046485     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24542     Document Type: Article

References (36)

1. Theodore D, Fried MW. Natural history and disease manifestations of hepatitis C infection. Curr Top Microbiol Immunol 2000; 242: 43-54.
2. Katze MG, He Y, Gale M, Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2: 675-687.
3. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55: 255-281.
4. Lemon SM. Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 2010; 285: 22741-22747.
5. Han JQ, Barton DJ. Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 2002; 8: 512-525.
6. Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 2001; 82: 723-733.
7. Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. HEPATOLOGY 2003; 37: 1180-1188.
8. Wang C, Pflugheber J, Sumpter R, Jr., Sodora DL, Hui D, Sen GC, Gale M, Jr. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 2003; 77: 3898-3912.
9. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 2008; 82: 1665-1678.
10. Zhou Z, Wang N, Woodson SE, Dong Q, Wang J, Liang Y, et al. Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology 2010; 409: 175-188.
11. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. HEPATOLOGY 2005; 42: 702-710.
12. Fitzgerald KA. The interferon inducible gene: viperin. J Interferon Cytokine Res 2010; 31: 131-135.
13. Hinson ER, Cresswell P. The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 2009; 106: 20452-20457.
14. Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002; 76: 2997-3006.
15. Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, Beard MR. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. HEPATOLOGY 2004; 39: 1220-1229.
16. Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol 2009; 83: 836-846.
17. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-796.
18. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 2001; 98: 15125-15130.
19. Kenworthy AK. Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 2001; 24: 289-296.
20. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Image. J Biophotonics Int 2004; 11: 36-42.
21. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000; 118: 152-162.
22. Sumpter R, Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005; 79: 2689-2699.
23. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007; 2: 96-105.
24. Hinson ER, Cresswell P. The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J Biol Chem 2009; 284: 4705-4712.
25. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007; 9: 1089-1097.
26. Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE, Goff SP, et al. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 2004; 78: 7400-7409.
27. Duschene KS, Broderick JB. The antiviral protein viperin is a radical SAM enzyme. FEBS Lett 2010; 584: 1263-1267.
28. Guo Y, Cordes KR, Farese RV, Jr., Walther TC. Lipid droplets at a glance. J Cell Sci 2009; 122: 749-752.
29. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, et al. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci U S A 2009; 106: 7577-7582.
30. Gao L, Aizaki H, He JW, Lai MM. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 2004; 78: 3480-3488.
31. Perelson AS, Herrmann E, Micol F, Zeuzem S. New kinetic models for the hepatitis C virus. HEPATOLOGY 2005; 42: 749-754.
32. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75: 8516-8523.
33. Lanford RE, Guerra B, Lee H, Averett DR, Pfeiffer B, Chavez D, et al. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 2003; 77: 1092-1104.
34. Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. HEPATOLOGY 2002; 35: 694-703.
35. Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, Chen ZJ, Gale M, Jr. Activation of the interferon-beta promoter during hepatitis C virus RNA replication. Viral Immunol 2002; 15: 29-40.
36. Severa M, Coccia EM, Fitzgerald KA. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J Biol Chem 2006; 281: 26188-26195.